In vitro studies on cell lines have confirmed that CXCR2 activation increases proliferation in various types of cancer, including colon cancer [75], esophageal carcinoma [76], gastric cancer [77], malignant melanoma [78], and ovarian cancer [74]. Here, CXCR2 is linked to malignant colon neoplasm.